You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)擬1.2億元收購上海申裕導線100%股權
格隆匯 01-21 20:16

格隆匯1月21日丨維亞生物(01873.HK)公告,於2020年1月21日,公司間接全資附屬公司維亞生物科技(上海)(作為買方)與賣方黃春豔及陶妹華訂立股權轉讓協議,據此,維亞生物科技(上海)有條件同意自賣方收購目標公司上海申裕導線有限公司100%股權,代價為人民幣1.2億元。收購事項完成後,目標公司將成為本公司的間接全資附屬公司。

目標公司為一間在中國成立的有限公司。於本公告日期,其註冊資本為人民幣859.14萬元(已悉數繳足)。其目前並無實質業務經營活動,物業為其主要資產。

集團為中國的綜合藥物開發平台並正以年租金約人民幣1150萬元租用物業。其認為收購事項將令本集團實現其業務發展規劃,節省租賃開支併為本集團提供穩定辦公及營運場所。預計物業將由本集團持有自用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account